Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 1,132.54 | 1,054.58 | 1,618.55 | 1,334.81 |
Depreciation/ Depletion | 344.57 | 146.74 | 110.30 | 98.78 |
Non- Cash Items | -120.96 | -108.54 | -138.49 | -81.48 |
Changesin Working Capital | -359.35 | -728.81 | -799.59 | -747.18 |
Cashfrom Operating Activities | 996.80 | 363.97 | 790.77 | 604.93 |
Capital Expenditures | -398.26 | -223.12 | -522.12 | -228.78 |
Other Investing Cash Flow Items Total | -1,358.66 | 1,431.31 | -480.50 | -1,295.22 |
Cashfrom Investing Activities | -1,756.91 | 1,208.19 | -1,002.62 | -1,524.00 |
Financing Cash Flow Items | -25.61 | -6.29 | -3.40 | -2.33 |
Issuance( Retirement)of Stock Net | 0.53 | 21.50 | 38.55 | 1,241.81 |
Issuance( Retirement)of Debt Net | -774.33 | -0.29 | -0.25 | -1.02 |
Cashfrom Financing Activities | -799.42 | 14.92 | 34.90 | 1,238.46 |
Foreign Exchange Effects | 7.72 | 3.00 | 3.31 | 3.58 |
Net Changein Cash | -1,551.81 | 1,590.08 | -173.64 | 322.97 |
Cash Interest Paid | 25.61 | 6.29 | 3.40 | 2.33 |
Cash Taxes Paid | 306.15 | 310.87 | 406.51 | 311.43 |
Gland Pharma Dividend Gland Pharma Bonus Gland Pharma News Gland Pharma AGM Gland Pharma Rights Gland Pharma Splits Gland Pharma Board Meetings Gland Pharma Key Metrics Gland Pharma Shareholdings Gland Pharma Profit Loss Gland Pharma Balance Sheet Gland Pharma Q1 Results Gland Pharma Q2 Results Gland Pharma Q3 Results Gland Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks